Perturbation of calreticulin potentiates CD8+ T cell–mediated antitumor immunity

Journal:

Journal of Experimental Medicine

Published:

2025-10-06

DOI:

10.1084/jem.20242360

Affiliations:

6

Authors:

13

Go to article

Institutions	Authors	Share
State Key Laboratory of Molecular Oncology, China	6.500000	0.50
Academy for Advanced Interdisciplinary Studies (AAIS), PKU, China	2.833333	0.22
Boehringer Ingelheim Pharmaceuticals, Inc., United States of America (USA)	2.000000	0.15
Peking University Chengdu Academy for Advanced Interdisciplinary Biotechnologies, China	0.833333	0.06
Tsinghua - PKU Joint Center for Life Sciences (CLS), China	0.833333	0.06

Interested in Immunology?